Vote Scores

Home / Companies / Ascendis Pharma A/S / 27 May 2025

Meeting · year to 30 June 2025159 filers reporting

Ascendis Pharma A/S: meeting of 27 May 2025

Votes reported on Form N-PX, item by item

159 Form N-PX filers reported votes at the Ascendis Pharma A/S meeting of 27 May 2025. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

6 nominees; 97.2% of reported votes for; 12 filers withheld from or voted against at least one nominee.

1,478 vote records from 155 filers. 1 of the 152 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

95.5% for0.0% against4.5% other0.7% against management155 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

2 vote records from 2 filers. 0 of the 2 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management2 filers100.0% for0.0% against0.0% against management185,730 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

244 vote records from 154 filers. 1 of the 151 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

97.4% for0.0% against2.6% other0.7% against management154 filers100.0% for0.0% against0.0% other0.0% against management23,169,971 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

683 vote records from 151 filers. 1 of the 148 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

97.4% for0.0% against2.6% other0.7% against management151 filers99.4% for0.6% against0.0% other0.6% against management65,673,938 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

227 vote records from 144 filers. 79 of the 141 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

41.7% for55.6% against2.8% other56.0% against management144 filers69.0% for31.0% against30.8% against management22,684,941 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

537 vote records from 156 filers. 1 of the 153 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

97.4% for0.0% against2.6% other0.7% against management156 filers99.6% for0.0% against0.4% other0.0% against management47,844,881 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

43 vote records from 18 filers. 0 of the 18 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management18 filers96.6% for0.0% against3.4% other0.0% against management2,613,715 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors3. Auditor
VanguardForFor
BlackRock and iSharesForFor
FidelityForFor
State Street and SPDRForFor
American CenturyForFor
Franklin TempletonForFor
InvescoForFor
EquitableForFor
ProShares and ProFundsForFor
John Hancock and ManulifeForFor
Morgan Stanley, Eaton Vance and CalvertForFor
J.P. MorganForFor
Goldman SachsForFor
Jackson National fundsForFor
Northern Trust and FlexSharesForFor
SEIForFor
T. Rowe PriceForFor
Lincoln FinancialForFor
VoyaForFor
Russell InvestmentsForFor
NationwideForFor
Victory CapitalForFor
Brighthouse FundsForFor
Guggenheim and RydexForFor
Columbia ThreadneedleForFor
BNY MellonForFor
PrincipalForFor
Capital Group and American FundsForFor
Pacific Life fundsForFor
MFSForFor
TransamericaForFor
AllianceBernsteinForFor
Hartford FundsForFor
AllspringForFor
MassMutualForFor
Harbor FundsForFor
Janus HendersonForFor
Neuberger BermanForFor
Natixis and Loomis SaylesForFor
Lord AbbettForFor
Artisan PartnersForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Ascendis Pharma A/S meeting?

159 Form N-PX filers reported votes at the meeting of 27 May 2025. On say-on-pay, 0 of 2 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Ascendis Pharma A/S on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Ascendis Pharma A/S

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Ascendis Pharma A/S with a meeting date within three days of 27 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.